2018 ODAC Global Learning Objectives

Upon completion of the 2018 ODAC, participants should be able to:

  • Define intrinsic and extrinsic factors of the normal aging process in patients with all skin types
  • Select and formulate the appropriate aesthetic treatment plan using neurotoxins, dermal fillers, laser and light-based energy therapy technologies and cosmeceutical products in patients of all skin types who seek improvement in facial and skin appearance
  • Compare patient selection, choice of injectable products and technique required to avoid potential complications and achieve optimal patient outcomes
  • Express current understanding of the pathophysiology of acne as it relates to effective diagnosis and treatment
  • Discuss current theories on the pathogenesis of rosacea including the identification of genetic factors and gene loci that predispose affected patients to a rosacea phenotype
  • Analyze evidence-based data on acne treatment options in order to improve treatment outcomes and improve patient adherence to therapy
  • Examine emerging clinical and therapeutic science insights into the pathogenesis and effective management of atopic dermatitis and summarize the recently published AAD clinical guidelines on the management of atopic dermatitis
  • Discuss the role of the innate and adaptive immune system function in normal skin and how changes in the immune system may contribute to inflammatory disease 
  • Identify the psoriasis patient population that would benefit most from treatment with biologic response modifiers 
  • Assess evidence-based data on the relationship between psoriasis comorbidities and therapeutic selection
  • Indicate the types of superficial fungal infection presenting in the dermatology setting
  • Formulate optimal treatment plans for difficult to treat onychomycosis and cutaneous superficial fungal infections including tinea pedis, tinea cruris and tinea corporis
  • Summarize current and emerging therapies that hold promise for the effective treatment of skin cancers including actinic keratosis, basal cell carcinoma and melanoma